Search

everythinglearnresearchcommunity

for

Search:↓

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Most pediatric cancer patients in the study developed skin problems, often due to their cancer treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

The model and estimator can predict drug exposure in kidney transplant patients well.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

The ILDS Newsletter reported on efforts to support albinism patients in Tanzania and dermatological conferences.

An elderly woman with cancer improved after treatment for a rare skin condition with coiled hairs.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

The objective approach for creating search strategies is as effective as the traditional method and might be better and more efficient.

Multiple plasma donations do not change donors' biochemical parameters.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

Millets may help reduce chemotherapy side effects like nausea, fatigue, and hair loss.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

TLR4 is important in aging-related diseases and could be a new treatment target.

Many research paper titles in dermatology journals lack scientific precision.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Adrenal disorders can cause lasting brain and behavior issues in children.